(Q34507186)

2 August 2017

1 reference

title

Neuroprotective actions of selegiline (English)

1 reference

2 August 2017

Ebadi M

1

1 reference

2 August 2017

Sharma S

series ordinal

2

1 reference

2 August 2017

Shavali S

series ordinal

3

1 reference

2 August 2017

El Refaey H

series ordinal

4

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Journal of Neuroscience Research

2 August 2017

published in

1 reference

2 August 2017

volume

67

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

285-289

1 reference

The effects of oxidative stress on in vivo brain GSH turnover in young and mature mice.

2 August 2017

cites work

1 reference

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

21 January 2018

1 reference

Oxidative stress and antioxidant therapy in Parkinson's disease

21 January 2018

1 reference

Neurotrophins and their receptors in nerve injury and repair.

21 January 2018

1 reference

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

21 January 2018

1 reference

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

21 January 2018

1 reference

L-Deprenyl prevents the cell hypoxia induced by dopaminergic neurotoxins, MPP(+) and beta-carbolinium: a microdialysis study in rats

21 January 2018

1 reference

New directions in the drug treatment of Parkinson's disease

21 January 2018

1 reference

Selegiline as initial treatment in de novo parkinsonian patients

21 January 2018

1 reference

Future of neuroprotection in Parkinson's disease

21 January 2018

1 reference

Selegiline and mortality in Parkinson's disease

21 January 2018

1 reference

Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section

21 January 2018

1 reference

An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. The Parkinson Study Group

21 January 2018

1 reference

Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites

21 January 2018

1 reference

Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.

21 January 2018

1 reference

Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.10148

1 reference

2 August 2017

1 reference